<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02447614</url>
  </required_header>
  <id_info>
    <org_study_id>BCH-OSAHS-002</org_study_id>
    <nct_id>NCT02447614</nct_id>
  </id_info>
  <brief_title>Follow-up Studies of Primary Snoring(PS) and Obstructive Sleep Apnea Hypopnea Syndrome(OSAHS) in Chinese Children</brief_title>
  <official_title>Follow-up Studies of PS and OSAHS in Chinese Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to investigate the natural course of Primary snoring in 1-2 years or
      more and the different effect of drug and surgical treatment applied in children with
      obstructive sleep apnea (OSAS) by comparing the polysomnography(PSG) and sleep questionaires
      in 6 months after treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The evolution of snoring and OSAS in children is not well established since few studies have
      been published.This study is designed to evaluate the evolution of primary snoring and OSAS
      in children who had been submitted to watchful waiting 、drug or adenotonsillectomy.The
      participated children will be evaluated by full physical examination and nocturnal
      polysomnography（PSG）, after which they were divided into 2 groups: apnea and snoring. After 6
      months following the initial evaluation, patients were submitted to a new nocturnal
      polysomnography, and all data were compared to those of the first examination.And after 3
      months and 12 months following the initial evaluation, patients will be called to complete
      the sleep questionnaire.Then analyse the change of parameters of polysomnography after 6
      months of follow-up,and describe the changes of items of sleep questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The changes of PSG parameters of children with PS or OSAS</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The changes of sleep questionnaires of children with PS or OSAS</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of level of leukotriene in urine of children with PS or OSAS</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of Heart rate variability (HRV) of children with PS or OSAS</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>The pictorial memory task acquisition and retention in children with OSAS</measure>
    <time_frame>0 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The changes of endothelial cell function in children with PS or OSAS</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adenotonsillectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conservative treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mometasone Furoate Aqueous Nasal Spray or uticasone propionate (1/once qd) and（or）Leukotriene antagonists(4 or 5mg/once qn) or H1 receptor antagonists</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>just regular follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adenotonsillectomy</intervention_name>
    <description>Adenotonsillectomy</description>
    <arm_group_label>Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conservative treatment</intervention_name>
    <description>Mometasone Furoate Aqueous Nasal Spray or uticasone propionate (1/once qd) and（or）Leukotriene antagonists(4 or 5mg/once qn) or H1 receptor antagonists</description>
    <arm_group_label>Conservative treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no treatment</intervention_name>
    <description>just regular follow-up</description>
    <arm_group_label>no treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 3-12 yrs, who are referred for clinical evaluation of habitual snoring
             and who were scheduled for an overnight polysomnogram.

        Exclusion Criteria:

          -  Children who are suffered from any chronic medical or psychiatric condition

          -  Children with acute respiratory infection

          -  Children with severe craniofacial deformities

          -  Children with cardiopulmonary diseases

          -  Children with a genetic syndrome that was known to affect cognitive abilities, or are
             receiving medications that are known to interfere with memory or sleep onset or heat
             rate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xu Zhifei, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xu Zhifei, MD,PhD</last_name>
    <phone>13521660077</phone>
    <email>zhifeixu@aliyun.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wu Yunxiao, MD</last_name>
    <phone>15811077989</phone>
    <email>hbjlwuyunxiao@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sleep Center,Beijing Children's Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100045</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xu Zhifei, MD,phD</last_name>
      <phone>010-59616395</phone>
      <email>zhifeixu@aliyun.com</email>
    </contact>
    <contact_backup>
      <last_name>Wu Yunxiao, MD</last_name>
      <phone>15811077989</phone>
      <email>hbjlwuyunxiao@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, Schechter MS, Ward SD, Sheldon SH, Shiffman RN, Lehmann C, Spruyt K; American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012 Sep;130(3):e714-55. doi: 10.1542/peds.2012-1672. Epub 2012 Aug 27. Review.</citation>
    <PMID>22926176</PMID>
  </reference>
  <reference>
    <citation>Xu Z, Li B, Shen K. Ambulatory blood pressure monitoring in Chinese children with obstructive sleep apnea/hypopnea syndrome. Pediatr Pulmonol. 2013 Mar;48(3):274-9. doi: 10.1002/ppul.22595. Epub 2012 May 21.</citation>
    <PMID>22615200</PMID>
  </reference>
  <reference>
    <citation>Tan HL, Gozal D, Kheirandish-Gozal L. Obstructive sleep apnea in children: a critical update. Nat Sci Sleep. 2013 Sep 25;5:109-23. doi: 10.2147/NSS.S51907. Review.</citation>
    <PMID>24109201</PMID>
  </reference>
  <reference>
    <citation>Kohler M. Risk factors and treatment for obstructive sleep apnea amongst obese children and adults. Curr Opin Allergy Clin Immunol. 2009 Feb;9(1):4-9. doi: 10.1097/ACI.0b013e32831d8184. Review.</citation>
    <PMID>19532087</PMID>
  </reference>
  <reference>
    <citation>Cheng J, Elden L. Outcomes in children under 12 months of age undergoing adenotonsillectomy for sleep-disordered breathing. Laryngoscope. 2013 Sep;123(9):2281-4. doi: 10.1002/lary.23796. Epub 2013 Jul 2.</citation>
    <PMID>23821577</PMID>
  </reference>
  <reference>
    <citation>Tagaya M, Nakata S, Yasuma F, Mitchell RB, Sasaki F, Miyazaki S, Morinaga M, Otake H, Teranishi M, Nakashima T. Children with severe or moderate obstructive sleep apnoea syndrome show a high incidence of persistence after adenotonsillectomy. Acta Otolaryngol. 2012 Nov;132(11):1208-14. doi: 10.3109/00016489.2012.695088. Epub 2012 Oct 1.</citation>
    <PMID>23025449</PMID>
  </reference>
  <reference>
    <citation>Shen Y, Xu Z, Shen K. Urinary leukotriene E4, obesity, and adenotonsillar hypertrophy in Chinese children with sleep disordered breathing. Sleep. 2011 Aug 1;34(8):1135-041. doi: 10.5665/SLEEP.1178.</citation>
    <PMID>21804676</PMID>
  </reference>
  <reference>
    <citation>Shen Y, Xu Z, Huang Z, Xu J, Qin Q, Shen K. Increased cysteinyl leukotriene concentration and receptor expression in tonsillar tissues of Chinese children with sleep-disordered breathing. Int Immunopharmacol. 2012 Aug;13(4):371-6. doi: 10.1016/j.intimp.2012.05.009. Epub 2012 May 23.</citation>
    <PMID>22634478</PMID>
  </reference>
  <reference>
    <citation>Tapia IE, Marcus CL. Newer treatment modalities for pediatric obstructive sleep apnea. Paediatr Respir Rev. 2013 Sep;14(3):199-203. doi: 10.1016/j.prrv.2012.05.006. Epub 2012 Jun 26. Review.</citation>
    <PMID>23931720</PMID>
  </reference>
  <reference>
    <citation>Friedman BC, Goldman RD. Anti-inflammatory therapy for obstructive sleep apnea in children. Can Fam Physician. 2011 Aug;57(8):891-3.</citation>
    <PMID>21841108</PMID>
  </reference>
  <reference>
    <citation>Kheirandish-Gozal L, Kim J, Goldbart AD, Gozal D. Novel pharmacological approaches for treatment of obstructive sleep apnea in children. Expert Opin Investig Drugs. 2013 Jan;22(1):71-85. doi: 10.1517/13543784.2013.735230. Epub 2012 Nov 5. Review.</citation>
    <PMID>23126687</PMID>
  </reference>
  <reference>
    <citation>Rosen D. Management of obstructive sleep apnea associated with Down syndrome and other craniofacial dysmorphologies. Curr Opin Pulm Med. 2011 Nov;17(6):431-6. doi: 10.1097/MCP.0b013e32834ba9c0. Review.</citation>
    <PMID>21918449</PMID>
  </reference>
  <reference>
    <citation>Heussler H, Chan P, Price AM, Waters K, Davey MJ, Hiscock H. Pharmacological and non-pharmacological management of sleep disturbance in children: an Australian Paediatric Research Network survey. Sleep Med. 2013 Feb;14(2):189-94. doi: 10.1016/j.sleep.2012.09.023. Epub 2012 Dec 12.</citation>
    <PMID>23245853</PMID>
  </reference>
  <reference>
    <citation>Goldbart AD, Greenberg-Dotan S, Tal A. Montelukast for children with obstructive sleep apnea: a double-blind, placebo-controlled study. Pediatrics. 2012 Sep;130(3):e575-80. doi: 10.1542/peds.2012-0310. Epub 2012 Aug 6.</citation>
    <PMID>22869829</PMID>
  </reference>
  <reference>
    <citation>Leboulanger N, Fauroux B. Non-invasive positive-pressure ventilation in children in otolaryngology. Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Apr;130(2):73-7. doi: 10.1016/j.anorl.2012.06.001. Epub 2012 Dec 27.</citation>
    <PMID>23273417</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2015</study_first_submitted>
  <study_first_submitted_qc>May 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2015</study_first_posted>
  <last_update_submitted>February 4, 2017</last_update_submitted>
  <last_update_submitted_qc>February 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Children's Hospital</investigator_affiliation>
    <investigator_full_name>Zhifei Xu</investigator_full_name>
    <investigator_title>The chief of Sleep center</investigator_title>
  </responsible_party>
  <keyword>follow up</keyword>
  <keyword>Primary Snoring</keyword>
  <keyword>Obstructive Sleep Apnea Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mometasone Furoate</mesh_term>
    <mesh_term>Leukotriene Antagonists</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

